Salicylic acid capsule is a commonly used anti-inflammatory and hepatoprotective therapeutic drug. It can stabilize the liver cell membrane and protect the liver enzyme system by binding with the liver cell membrane protein; capture the free oxygen free radicals in the liver cell, prevent the mitochondria from being oxidized, and prevent the oxidation of damaged proteins.

Salicylic acid capsule can also inhibit the release of superoxide anion from neutrophils and play the role of antioxidant, which can reduce the level of a variety of pro-inflammatory factors and achieve anti-inflammatory effect.

Through antioxidant and direct inhibition of activation of hepatic stellate cells by various cytokines, it achieves anti-fibrotic effect; it can reduce the triglyceride (TG) content and serum TG and total cholesterol (TCh) levels in the liver, and improves steatosis and ballooning of the liver.

Extended information:

Dosage

The average patient needs to take the medication orally (with warm water can also be taken), and the dose of the medication is 2-4 capsules each time, which can be taken three times in a day or as prescribed by the doctor. In order not to affect the gastrointestinal tract, patients can use the drug after meals, to reduce the phenomenon of the drug directly irritating the lining of the gastrointestinal tract. In the case of people who are allergic to the drug, they will be prohibited from using the drug to avoid an allergic reaction.

When taking silymarin capsules, try to take it with warm boiled water, which is good for the absorption of the drug. During the period of taking the drug, it is better not to eat greasy, spicy, raw and cold food, so as not to affect the absorption of the drug by the stomach, and reduce the efficacy of silymarin capsules.

The contraindication to the use of silymarin capsules (ShuiLinJia) is that it is contraindicated in pregnant women, and should be used with caution in allergic patients. Patients who accidentally use it do not need to panic, they should calmly look for a solution.

People's Daily Online - China's drug-related liver injury epidemiology research has made new progress